KASINGER JAMES R. sold CRSP
February 19, 2026 · Form 4 insider transaction
KASINGER JAMES R. sold 2,112 shares of CRISPR Therapeutics AG at $52.58 per share, a transaction worth $111.0K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
2,112
Price
$52.58
Total value
$111.0K
InsiderKASINGER JAMES R.
RoleOfficer
SecurityCommon Shares
Transaction codeS: Open-market sale
Transaction dateFebruary 19, 2026
Filing dateFebruary 20, 2026
Shares owned after85,115
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person.